Two years ago, the Food and Drug Association (FDA) was still uncertain about how to address growing concerns over the effects of metal-on-metal (MoM) hip implants. So, on June 27, 2012, the FDA’s Orthopaedic and Rehabilitation Devices Panel convened an Advisory Committee in order to hear experts and the public […]
Author: Brenda Fulmer
This blog is a continuation of “The FDA’s MoM Panel” which you should read first in order to have a clear idea of what happened at this important event. Click here to go back to Part I. The Manufacturers All major manufacturers still selling MoM hip implants were invited to […]
The NuvaRing New Jersey court has just announced today that a settlement agreement has been reached between Plaintiffs’ counsel and Merck for a sum of $100 million. NuvaRing is a popular contraceptive among women that increases the risk for fatal blood clots. The device is produced by Merck and its […]
The start of 2014 has seen some very significant developments in the national Biomet metal-on-metal hip implant litigation. Perhaps the most significant development though is Biomet’s offering, and the court’s acceptance, of a settlement for claimants who have undergone revision surgeries. On February 3, 2014, Judge Miller entered an order […]
Johnson & Johnson is no longer on the hook to pay the state of Louisiana $257.7 million for the way it marketed the antipsychotic drug Risperdal. At the end of January, the Louisiana Supreme Court overturned a 2012 appeals court verdict which said J&J was liable for deceptive marketing. In […]
Despite all the company assurances that the anticoagulant Pradaxa is a superior alternative to warfarin, the Food and Drug Administration (FDA) plans to once again compare the two. Pradaxa was approved in 2010 but has since then brought a high complication rate to its users – including dangerous and uncontrolled bleeding […]
A simple hernia repair surgery. Most doctors sell it as a walk in the park depending on the hernia and certainly the standard of care is to use surgical mesh. But a new study from the American College of Surgeons (ACS) finds the simple surgery for ventral hernia repair can […]
A trio of studies published in the Journal of the American Medical Association (JAMA) finds that just because a drug or medical device makes it to market does not necessarily mean it’s been tested and is safe and effective beyond all doubt. According to three published reviews, the same standards […]
The Arkansas Supreme Court is ready to listen to Johnson & Johnson’s appeal of a verdict and $1.2 billion fine over the illegal marketing of the drug Risperdal. Little Rock will be the setting for the oral arguments, which take place on February 27. The Arkansas Attorney General successfully sued J&J […]
Lawyers for Merck & Co. are prepared to put the Fosamax chapter behind them. The company has announced it will pay $27.7 million to settle lawsuits filed by those patients on the osteoporosis drug who suffered necrosis or deterioration of the jaw bone. The settlement will affect nearly 1,200 people […]
